Arginase expression and modulation of IL-1β-induced nitric oxide generation in rat and human islets of Langerhans

Nitric Oxide - Biology and Chemistry

Volumn 7, Issue 4, 2002, Pages 289-296

  Stickings, P ^a   Mistry, S K ^b   Boucher, J L ^c   Morris Jr , S M ^b   Cunningham, J M ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

2(S) amino 6 boronohexanoic acid; Arginase; Islets of Langerhans; Nitric oxide synthase; RINm5F; Type 1 diabetes

Indexed keywords

2 AMINO 6 BORONOHEXANOIC ACID; ARGINASE; ARGININE; ENZYME INHIBITOR; HEXANOIC ACID DERIVATIVE; INTERLEUKIN 1BETA; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG; 2-AMINO-6-BORONOHEXANOIC ACID; AMINOCAPROIC ACID DERIVATIVE; BORON DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; NOS2 PROTEIN, RAT; NOS2A PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DESTRUCTION; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; KIDNEY; LIVER; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNTHESIS; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; INSULINOMA; METABOLISM; NORTHERN BLOTTING;

AMINOCAPROIC ACIDS; ANIMALS; ARGINASE; ARGININE; BLOTTING, NORTHERN; BLOTTING, WESTERN; BORON COMPOUNDS; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; INSULINOMA; INTERLEUKIN-1; ISLETS OF LANGERHANS; ISOENZYMES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; TUMOR CELLS, CULTURED;

EID: 0036433224     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-8603(02)00122-2     Document Type: Article

References (60)

1. C.P. Jenkinson, W.W. Grody, S.D. Cederbaum, Comparative properties of arginases, Comp. Biochem. Phys. 114 (1996) 107-132.
2. G. Wu, S.M. Morris Jr., Arginine metabolism: Nitric oxide and beyond, Biochem. J. 336 (1) (1998) 1-17.
3. S.M. Morris Jr., Regulation of enzymes of urea and arginine synthesis, Annu. Rev. Nutr. 12 (1992) 81-101.
4. T. Gotoh, T. Sonoki, A. Nagasaki, K. Terada, M. Takiguchi, M. Mori, Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line, FEBS Lett. 395 (2-3) (1996) 119-122.
5. J.G. Vockley, C.P. Jenkinson, H. Shukla, R.M. Kern, W.W. Grody, S.D. Cederbaum, Cloning and characterization of the human type II arginase gene, Genomics 38 (1996) 118-123.
6. S.M. Morris, D. Bhamidipati, D. Kepka-Lenhart, Human type II arginase: Sequence analysis and tissue-specific expression, Gene 193 (1997) 157-161.
7. W.J. Malaisse, F. Blachier, A. Mourtada, J. Camara, A. Albor, I. Valverde, A. Sener, Stimulus-secretion coupling of arginine-induced insulin release. Metabolism of L-arginine and L-ornithine in pancreatic islets, Biochim. Biophys. Acta. 1013 (1989) 133-143.
8. W.J. Malaisse, F. Blachier, A. Mourtada, J. Camara, A. Albor, I. Valverde, A. Sener, Stimulus-secretion coupling of arginine-induced insulin release: metabolism of L-arginine and L-ornithine in tumoral islet cells, Mol. Cell. Endocrinol. 67 (1989) 81-91.
9. J.M. Cunningham, J.G. Mabley, I.C. Green, Interleukin 1β-mediated inhibition of arginase in RINm5F cells, Cytokine 9 (8) (1997) 570-576.
10. A.K. Cardozo, M. Kruhøffer, R. Leeman, T. Orntoft, D.L. Eizirik, Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays, Diabetes 50 (2001) 909-920.
11. K. Rieneck, L. Frier Bovin, K. Josefsen, K. Buschard, M. Svenson, K. Bendtzen, Massive parallel gene expression profiling of RINm5F pancreatic islet β-cells stimulated with interleukin-1b, APMIS 108 (2000) 855-872.
12. J.L. Boucher, C. Moali, J.-P. Tenu, Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization, Cell. Mol. Life Sci. 55 (8-9) (1999) 1015-1028.
13. M. Mori, T. Gotoh, Regulation of nitric oxide production by arginine metabolic enzymes, Biochem. Biophys. Res. Commun. 275 (2000) 715-719.
14. C.-I. Chang, J.C. Liao, L. Kuo, Arginase modulates nitric oxide production in activated macrophages, Am. J. Physiol. 274 (1998) H342-H348.
15. w-Hydroxy-nor-L-arginine on NO synthase activity in murine macrophages, Nitric Oxide. 3 (6) (1999) 427-438.
16. H2 cytokines, Eur. J. Immunol. 25 (1995) 1101-1104.
17. S.N. Waddington, K. Mosley, H.T. Cook, F.W.K. Tam, V. Cattell, Arginase AI is upregulated in acute immune complex-induced inflammation, Biochem. Biophys. Res. Commun. 247 (1998) 84-87.
18. M. Munder, K. Eichmann, G. Soler, F. Centeno, M. Modolell, Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells, J. Immunol. 163 (1999) 3771-3777.
19. L.H. Wei, A.T. Jacobs, S.M. Morris Jr., L.J. Ignarro, IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells, Annu. Rev. Physiol. 279 (2000) C248-C256.
20. S.S. Gross, M.S. Wolin, Nitric oxide: Pathophysiological mechanisms, Annu. Rev. Physiol. 57 (1995) 737-769.
21. I.M. Corraliza, G. Soler, K. Eichmann, M. Modolell, Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10, PGE-2) in murine-bone marrow-derived macrophages, Biochem. Biophys. Res. Commun. 206 (2) (1995) 667-673.
22. 1 T cells correlates with Th1/Th2 phenotype, J. Immunol. 160 (1998) 5347-5354.
23. A. Rabinovitch, W.L. Suarez-Pinzon, Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochem. Pharmacol. 55 (1998) 1139-1149
24. A. Rabinovitch, W.L. Suarez-Pinzon, A. El-Sheikh, O. Sorensen, R.F. Power, Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats-Expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM, Diabetes 45 (1996) 749-754.
25. H.Y. Qin, B. Singh, BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide, J. Autoimmun. 10 (3) (1997) 271-278.
26. H.-S. Jun, C.-S. Yoon, L. Zbytnuik, N. van Rooijen, J.-W. Yoon, The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice, J. Exp. Med. 189 (2) (1999) 347-358.
27. M.N. Bradley, V.C. Asensio, L.-K. Schioetz, J. Harbertson, T. Krahl, G. Patstone, N. Woolf, I.L. Campbell, N. Sarvetnick, Islet specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes, J. Immunol. 162 (1999) 2511-2520.
28. A. Rabinovitch, An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus, Diabetes/Metab. Rev. 14 (2) (1998) 129-151.
29. D.L. Eizirik, M.I. Darville, β-cell apoptosis and defence mechanisms, Diabetes 50 (Suppl. 1) (2001) S64-S69.
30. 2+-arginase by 2 borate leads to the design of a transition state analogue inhibitor, 2(S)-amino-6-boronohexanoic acid, J. Am. Chem. Soc. 119 (1997) 8107-8108.
31. S. Collett, F. Carreaux, J.L. Boucher, S. Pethe, M. Lepoivre, R. Danion-Bougot, D. Danion, Synthesis and evaluation of ω-borono-α-amino acids as active site probes of arginase and nitric oxide synthases, J. Chem. Soc. Perkin Trans. 1 (2000) 177-182.
32. A.F. Gazdar, W.L. Chick, H.K. Oie, H.L. Sims, D.L. King, G.C. Weir, V. Lauris, Continuous, clonal, insulin and somatostatin-secreting cell lines established from a transplantable rat islet cell tumour, Proc. Natl. Acad. of Sci. USA 77 (6) (1980) 3519-3523.
33. A.J. Bone, P.R. Hitchcock, D.J. Gwilliam, J.M. Cunningham, J. Barley, Insulitis and mechanisms of disease resistance: Studies in an animal model of insulin dependent diabetes mellitus, J. Mol. Med. 77 (1) (1999) 57-61.
34. V. Hadjivassiliou, M.H.L. Green, R.F.L. James, S.M. Swift, H.A. Clayton, I.C. Green, Insulin secretion, DNA damage, and apoptosis in human and rat islets of Langerhans following exposure to nitric oxide, peroxynitrite, and cytokines, Nitric Oxide 2 (6) (1998) 429-441.
35. E.B. Spector, M. Kiernan, B. Bernard, S.D. Cederbaum, Properties of fetal and adult red blood cell arginase: A possible prenatal diagnostic test for arginase deficiency, Am. J. Human Genet. 32 (1980) 79-87.
36. S.M. Morris Jr., D. Kepka-Lenhart, L.-C. Chen, Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells, Am. J. Physiol. 275 (38) (1998) E1-E8.
37. S. Kawamoto, Y. Amaya, K. Murakami, F. Tokunaga, S. Iwanaga, K. Kobayashi, T. Saheki, S. Kimura, M. Mori, Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver arginase, J. Biol. Chem. 262 (13) (1987) 6280-6283.
38. S.M. Morris, C.L. Moncman, K.D. Rand, G.J. Dizikes, S.D. Cederbaum, W.E. O'Brien, Regulation of mRNA levels for five urea cycle enzymes in rat liver by diet, cyclic AMP and glucocorticoids, Arch. Biochem. Biophys. 256 (1) (1987) 343-353.
39. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, Analysis of nitrate, nitrite, and [N-15]-labeled nitrate in biological fluids, Anal. Biochem. 126 (1) (1982) 131-138.
40. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
41. A. Sener, F. Blachier, W.J. Malaisse, Production of urea but absence of urea cycle in pancreatic islet cells, Med. Sci. Res. 16 (1988) 483-484.
42. D.M. Hougaard, J.H. Nielsen, L.-I. Larsson, Localisation and biosynthesis of polyamines in insulin-producing cells, Biochem. J. 238 (1986) 43-47.
43. N. Welsh, A. Sjöholm, Polyamines and insulin production in isolated mouse pancreatic islets, Biochem. J. 252 (3) (1988) 701-707.
44. A. Sjöholm, Role of polyamines in the regulation of proliferation and hormone production by insulin-secreting cells, Am. J. Physiol. 264 (1993) C501-C518.
45. A. Sjöholm, Effects of secretagogues on insulin biosynthesis and secretion in polyamine-depleted pancreatic β-cells, Am. J. Physiol. 270 (1996) C1105-C1110.
46. J.P. Jakway, H.G. Morris, E.J. Blumenthal, D.W. Talmage, Serum factors required for arginase induction in macrophages, Cell. Immunol. 54 (1980) 253-263.
47. C.A. Louis, V. Mody, W.L. Henry, J.S. Reichner, J.E. Albina, Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages, Am. J. Physiol. 276 (1999) R237-R242.
48. D.M. Colleluori, D.E. Ash, Classical and slow-binding inhibitors of human type II arginase, Biochemistry 40 (2001) 9356-9362.
49. R. Baggio, F.A. Emig, D.W. Christianson, D.E. Ash, S. Chakder, S. Rattan, Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor, J. Pharmacol. Exp. Ther. 290 (3) (1999) 1409-1416.
50. w-hydroxy-nor-L-arginine: A high-aLnity inhibitor of arginase well adapted to bind to its manganese cluster, J. Am. Chem. Soc. 119 (1997) 4086-4087.
51. O.W. GriLth, D.J. Stuehr, Nitric oxide synthases: Properties and catalytic mechanism, Annu. Rev. Physiol. 57 (1995) 707-736.
52. R. Rutschman, R. Lang, M. Hesse, J.N. Ihle, T.A. Wynn, P.J. Murray, Stat6-dependent substrate depletion regulates nitric oxide production, J. Immunol. 166 (2001) 2173-2177.
53. T. Gotoh, M. Mori, Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells, J. Cell Biol. 144 (3) (1999) 427-434.
54. H. Li, C.J. Meininger, J.A Hawker Jr., T.E. Haynes, D. Kepka-Lenhart, S.K. Mistry, S.M. Morris Jr., G. Wu, Regulatory role of arginase I and II in nitric oxide, polyamine, and proline synthesis in endothelial cells, Am. J. Physiol. 280 (2001) E75-E82.
55. L. Castillo, T.E. Chapman, M. Sanchez, Y.-M. Yu, J.F. Burke, A.M. Ajami, J. Vogt, V.R. Young, Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets, Proc. Natl. Acad. of Sci. USA 90 (1993) 7749-7753.
56. J.E. Albina, C.D. Mills, W.L. Henry, M.D. Caldwell, Temporal expression of different pathways of L-arginine metabolism in healing wounds, J. Immunol. 144 (10) (1990) 3877-3880.
57. G-hydroxy-L-Arginine: Implications for the regulation of nitric oxide biosynthesis by arginase, Biochem. Biophys. Res. Commun. 202 (1) (1994) 174-180.
58. G-hydroxy-L-arginine in alveolar macrophages: Implications for the utilization of L-arginine for nitric oxide synthesis, FEBS Lett. 359 (1995) 251-254.
59. G-hydroxyarginine during high-output nitric oxide production, Am. J. Physiol. 271 (1996) H1988-H1998.
60. H. Rothe, A. Hausmann, H. Kolb, Immunoregulation during disease progression in prediabetic NOD mice: Inverse expression of arginase and prostaglandin H synthase 2 vs. interleukin-15, Horm. Metab. Res. 34 (2002) 7-12.